ECM
DXCM icon

Everence Capital Management’s DexCom DXCM Stock Holding History

Everence Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Buy
6,820
+1,698
+33% +$113K 0.02% 445
2026
Q1 		$322K Buy
+5,122
New +$357K 0.02% 538
2025
Q4 		– Sell
-10,461
Closed -$704K – 796
2025
Q3 		$704K Buy
10,461
+4,251
+68% +$336K 0.04% 305
2025
Q2 		$542K Sell
6,210
-5,700
-48% -$447K 0.03% 350
2025
Q1 		$813K Buy
11,910
+380
+3% +$31K 0.06% 264
2024
Q4 		$897K Sell
11,530
-8,940
-44% -$662K 0.06% 248
2024
Q3 		$1.37M Buy
20,470
+14,800
+261% +$1.22M 0.09% 177
2024
Q2 		$722K Hold
5,670
– – 0.05% 284
2024
Q1 		$786K Hold
5,670
– – 0.05% 277
2023
Q4 		$704K Sell
5,670
-3,900
-41% -$398K 0.05% 299
2023
Q3 		$893K Hold
9,570
– – 0.07% 240
2023
Q2 		$1.12M Hold
9,570
– – 0.09% 191
2023
Q1 		$1.11M Hold
9,570
– – 0.09% 196
2022
Q4 		$1.08M Buy
9,570
+5,130
+116% +$563K 0.09% 187
2022
Q3 		$358K Sell
4,440
-14,830
-77% -$1.26M 0.03% 454
2022
Q2 		$1.44M Buy
19,270
+8,270
+75% +$755K 0.13% 144
2022
Q1 		$1.41M Hold
11,000
– – 0.11% 154
2021
Q4 		$1.48M Hold
11,000
– – 0.11% 161
2021
Q3 		$1.5M Hold
11,000
– – 0.12% 144
2021
Q2 		$1.17M Hold
11,000
– – 0.1% 180
2021
Q1 		$988K Hold
11,000
– – 0.09% 189
2020
Q4 		$1.02M Buy
11,000
+3,240
+42% +$289K 0.1% 168
2020
Q3 		$800K Buy
+7,760
New +$811K 0.09% 187

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Everence Capital Management's DXCM Position: Q2 2026 in Review

Everence Capital Management increased its DexCom (DXCM) stake by 33% in Q2 2026, buying an estimated $113K and bringing the position to 6,820 shares worth $459K. The position accounts for 0.02% of the portfolio, ranked #445.

Everence Capital Management first reported a position in DXCM in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.5M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Everence Capital Management held 6,820 shares of DexCom worth $459K as of Q2 2026.
  • Everence Capital Management bought 1,698 DexCom shares in Q2 2026, an estimated $113K.
  • DexCom made up 0.02% of Everence Capital Management's portfolio in Q2 2026, its #445 holding.
  • Everence Capital Management first reported a position in DexCom in Q3 2020 and has held it in 23 quarters since.
  • Everence Capital Management's DexCom position peaked at $1.5M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.